CRMD
Income statement / Annual
Last year (2025), CorMedix Inc's total revenue was $311.71 M,
an increase of 617.03% from the previous year.
In 2025, CorMedix Inc's net income was $163.06 M.
See CorMedix Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$311.71 M |
$43.47 M |
$0.00 |
$65.41 K |
$190.94 K |
$239.23 K |
$283.27 K |
$429.80 K |
$329.33 K |
$224.11 K |
| Cost of Revenue |
$35.96 M
|
$3.19 M
|
$205.56 K
|
$3.73 K
|
$148.94 K
|
$204.85 K
|
$373.23 K
|
$396.79 K
|
$114.96 K
|
$366.67 K
|
| Gross Profit |
$275.75 M
|
$40.28 M
|
-$205.56 K
|
$61.67 K
|
$42.00 K
|
$34.39 K
|
-$89.97 K
|
$33.01 K
|
$214.36 K
|
-$142.57 K
|
| Gross Profit Ratio |
0.88
|
0.93
|
0
|
0.94
|
0.22
|
0.14
|
-0.32
|
0.08
|
0.65
|
-0.64
|
| Research and Development Expenses |
$19.33 M
|
$3.94 M
|
$13.16 M
|
$10.68 M
|
$13.13 M
|
$13.38 M
|
$11.05 M
|
$18.82 M
|
$24.49 M
|
$15.74 M
|
| General & Administrative Expenses |
$68.22 M
|
$29.96 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$8.07 M
|
$8.65 M
|
$8.88 M
|
| Selling & Marketing Expenses |
-$38.05 M
|
$28.74 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$30.17 M
|
$58.70 M
|
$35.60 M
|
$20.01 M
|
$16.35 M
|
$13.88 M
|
$0.00
|
$8.07 M
|
$8.65 M
|
$8.88 M
|
| Other Expenses |
$76.11 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$9.87 M
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$125.61 M
|
$62.64 M
|
$48.75 M
|
$30.69 M
|
$29.48 M
|
$27.26 M
|
$20.92 M
|
$26.90 M
|
$33.14 M
|
$24.62 M
|
| Cost And Expenses |
$161.57 M
|
$65.83 M
|
$48.96 M
|
$30.69 M
|
$29.63 M
|
$27.46 M
|
$21.29 M
|
$27.29 M
|
$33.25 M
|
$24.99 M
|
| Interest Income |
$3.85 M
|
$2.58 M
|
$2.68 M
|
$326.02 K
|
$14.40 K
|
$116.07 K
|
$322.67 K
|
$36.62 K
|
$110.71 K
|
$126.77 K
|
| Interest Expense |
$2.78 M
|
$36.41 K
|
$0.00
|
$26.52 K
|
$15.94 K
|
$33.23 K
|
$787.49 K
|
$1.87 K
|
$5.62 K
|
$1.31 K
|
| Depreciation & Amortization |
$14.99 M
|
$309.78 K
|
$70.76 K
|
$209.04 K
|
$177.02 K
|
$143.49 K
|
$73.29 K
|
$74.22 K
|
$36.89 K
|
$25.60 K
|
| EBITDA |
$165.13 M |
-$18.98 M |
-$46.23 M |
-$30.05 M |
-$29.38 M |
-$27.02 M |
-$20.93 M |
-$26.75 M |
-$32.97 M |
-$24.62 M |
| EBITDA Ratio |
0.53
|
-0.44
|
0
|
-459.45
|
-153.85
|
-112.95
|
-73.9
|
-62.25
|
-100.12
|
-109.85
|
| Operating Income Ratio |
0.48
|
-0.51
|
0
|
-468.2
|
-154.18
|
-113.78
|
-74.16
|
-62.5
|
-99.97
|
-110.49
|
| Total Other Income/Expenses Net |
-$125.00 K
|
$3.03 M
|
$2.62 M
|
$336.65 K
|
-$22.83 K
|
$23.67 K
|
$9.64 M
|
$34.57 K
|
-$85.80 K
|
$117.29 K
|
| Income Before Tax |
$150.02 M
|
-$19.32 M
|
-$46.34 M
|
-$30.29 M
|
-$29.46 M
|
-$27.20 M
|
-$11.37 M
|
-$26.83 M
|
-$33.01 M
|
-$24.64 M
|
| Income Before Tax Ratio |
0.48
|
-0.44
|
0
|
-463.05
|
-154.29
|
-113.69
|
-40.15
|
-62.42
|
-100.23
|
-109.96
|
| Income Tax Expense |
-$13.04 M
|
-$1.39 M
|
$0.00
|
-$585.62 K
|
-$1.25 M
|
-$5.17 M
|
$5.06 M
|
$36.44 K
|
-$31.27 K
|
$1.31 K
|
| Net Income |
$163.06 M
|
-$17.93 M
|
-$46.34 M
|
-$29.70 M
|
-$28.21 M
|
-$22.03 M
|
-$16.43 M
|
-$26.83 M
|
-$33.01 M
|
-$24.64 M
|
| Net Income Ratio |
0.52
|
-0.41
|
0
|
-454.1
|
-147.75
|
-92.08
|
-58.01
|
-62.42
|
-100.23
|
-109.96
|
| EPS |
2.25 |
-0.3 |
-0.91 |
-0.74 |
-0.75 |
-0.77 |
-0.68 |
-1.51 |
-2.99 |
-3.25 |
| EPS Diluted |
2.04 |
-0.3 |
-0.91 |
-0.74 |
-0.75 |
-0.77 |
-0.68 |
-1.51 |
-2.99 |
-3.25 |
| Weighted Average Shares Out |
$72.03 M
|
$58.87 M
|
$50.90 M
|
$40.14 M
|
$37.61 M
|
$28.56 M
|
$24.15 M
|
$17.82 M
|
$11.03 M
|
$7.59 M
|
| Weighted Average Shares Out Diluted |
$80.31 M
|
$58.87 M
|
$50.90 M
|
$40.27 M
|
$37.67 M
|
$28.56 M
|
$24.15 M
|
$17.82 M
|
$11.03 M
|
$7.59 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
